Literature DB >> 9463743

Biological variation of cardiac markers: analytical and clinical considerations.

S M Ross1, C G Fraser.   

Abstract

The analytical, within-subject and between-subject components of variation were estimated for serum total creatine kinase (TCK) activity, CK-MB (creatine kinase-MB) activity, CK-MB mass, ratios of CK-MB activity and CK-MB mass to TCK activity and myoglobin concentration in a cohort of 16 apparently healthy subjects over 5 days. Analytical goals based on biological variation showed that, for all quantities except CK-MB mass, methodological improvement is warranted. All cardiac markers showed marked individuality which casts doubt on the utility of conventional population-based reference values as interpretative criteria. The critical differences required for significance of changes in serial results differ markedly from marker to marker and the data allow generation of objective criteria for monitoring individuals.

Mesh:

Substances:

Year:  1998        PMID: 9463743     DOI: 10.1177/000456329803500110

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  5 in total

1.  Multicentre evaluation of the diagnostic value of cardiac troponin T, CK-MB mass, and myoglobin for assessing patients with suspected acute coronary syndromes in routine clinical practice.

Authors:  P O Collinson; P J Stubbs; A-C Kessler
Journal:  Heart       Date:  2003-03       Impact factor: 5.994

2.  Reference change values of blood analytes from physically active subjects.

Authors:  Lázaro Alessandro S Nunes; René Brenzikofer; Denise Vaz de Macedo
Journal:  Eur J Appl Physiol       Date:  2010-05-06       Impact factor: 3.078

3.  Safe discharge from the cardiac emergency room with a rapid rule-out myocardial infarction protocol using serial CK-MB(mass).

Authors:  R Bholasingh; R J de Winter; J C Fischer; R W Koster; R J Peters; G T Sanders
Journal:  Heart       Date:  2001-02       Impact factor: 5.994

4.  Biological variation of ischaemia-modified albumin in healthy subjects.

Authors:  R Govender; J De Greef; R Delport; P J Becker; W J Vermaak
Journal:  Cardiovasc J Afr       Date:  2008 May-Jun       Impact factor: 1.167

5.  Biological variation of immunological blood biomarkers in healthy individuals and quality goals for biomarker tests.

Authors:  Najib Aziz; Roger Detels; Joshua J Quint; David Gjertson; Timothy Ryner; Anthony W Butch
Journal:  BMC Immunol       Date:  2019-09-14       Impact factor: 3.594

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.